Lung MRI in small rodents as a tool for the evaluation of drugs in models of airways diseases

In Vivo MR Techniques in Drug Discovery and Development

Volumn , Issue , 2006, Pages 351-372

  Beckmann, Nicolau ^a   Crémillieux, Yannick ^b   Tigani, Bruno ^a   Quintana, Harry Karmouty ^a   Blé, François Xavier ^a   Fozard, John R ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36148984006     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (102)

1. Kroegel, C. et al., Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I), Eur. Respir. J., 7, 519, 1994.
2. Barnes, P. J., Pathophysiology of asthma, Br. J. Clin. Pharmacol., 42, 3, 1996.
3. Moqbel, R., Eosinophil-derived cytokines in allergic inflammation and asthma, Ann. N.Y. Acad. Sci., 796, 209, 1996.
4. Sethi, S., Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease, Semin. Respir. Crit. Care Med., 26, 192, 2005.
5. Barnes, P. J., New treatments for COPD, Nat. Rev. Drug Discov., 1, 437, 2002.
6. Beckmann, N. et al., Magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs, Trends Pharmacol. Sci., 24, 550, 2003.
7. 2 and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging, Eur. J. Radiol., 29, 245, 1999.
8. Beckmann, N. et al., MRI of lung parenchyma in rats and mice using a gradient-echo sequence, NMR Biomed., 14, 297, 2001.
9. Beckmann, N. et al., Proton MRI of lung parenchyma reflects allergen-induced airway remodeling and endotoxin-aroused hyporesponsiveness: a step towards ventilation studies in spontaneously breathing rats, Magn. Reson. Med., 52, 258, 2004.
10. Kveder, M. et al., Water proton relaxation mechanisms in lung tissue, Magn. Reson. Med., 7, 432, 1988.
11. Burney, C. H., Bertolina, J., and Ailion, D. C., Calculation and interpretation of inhomogeneous line broadening in models of lung and other heterogeneous structures, J. Magn. Reson., 85, 554, 1989.
12. Bergin, C. J., Pauly, J. M., and Macovski, A., Lung parenchyma: projection reconstruction MR imaging, Radiology, 179, 777, 1991.
13. Gewalt, S. L. et al., MR microscopy of the rat lung using projection reconstruction, Magn. Reson. Med., 29, 99, 1993.
14. Bergin, C. J. et al., MR imaging of lung parenchyma: a solution to susceptibility, Radiology, 183, 673, 1992.
15. Ahn, C. B., Kim, J. H., and Cho, Z. H., High speed spiral-scan echo planar NMR imaging, IEEE MI-5, 1, 2, 1986.
16. Liao, J. R. et al., Reduction of motion artifacts in cine MRI using variable-density spiral trajectories, Magn. Reson. Med., 37, 569, 1997.
17. Hedlund, L. W. et al., MR-compatible ventilator for small animals: computer-controlled ventilation for proton and noble gas imaging, Magn. Reson. Imaging, 18, 753, 2000.
18. Beckmann, N. et al., Pulmonary edema induced by allergen challenge in the rat: noninvasive assessment by magnetic resonance imaging, Magn. Reson. Med., 45, 88, 2001.
19. Edelman, R. R. et al., Noninvasive assessment of regional ventilation in the human lung using oxygenenhanced magnetic resonance imaging, Nature Med., 2, 1236, 1996.
20. Morris, A. H. et al., A new nuclear magnetic resonance property of lung, J. Appl. Physiol., 58, 759, 1985.
21. Case, T. A. et al., A mathematical model of diamagnetic line broadening in lung tissue and similar heterogeneous systems: calculations and measurements, J. Magn. Reson., 73, 304, 1987.
22. Kuethe, D. O. et al., Imaging lungs using inert fluorinated gases, Magn. Reson. Med., 39, 85, 1998.
23. Kuethe, D. O. et al., Imaging obstructed ventilation with NMR using inert fluorinated gases, J. Appl. Physiol., 88, 2279, 2000.
24. Kuethe, D. O., Behr, V. C., and Begay, S., Volume of rat lungs measured throughout the respiratory cycle using 19F NMR of the inert gas SF6, Magn. Reson. Med., 48, 547, 2002.
25. Goodson, B. M., Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms, J. Magn. Reson., 155, 157, 2002.
26. Möller, H. E. et al., MRI of the lungs using hyperpolarized noble gases, Magn. Reson. Med., 47, 1029, 2002.
27. Albert, M. S. et al., Biological magnetic resonance imaging using laser-polarized 129Xe, Nature, 370, 199, 1994.
28. Middleton, H. et al., MR imaging with hyperpolarized 3He gas, Magn. Reson. Med., 33, 271, 1995.
29. Oros, A. M. and Shah, N. J., Hyperpolarized xenon in NMR and MRI, Phys. Med. Biol., 49, R105, 2004.
30. Kauczor, H.-U., Surkau, R., and Roberts, T., MRI using hyperpolarized noble gases, Eur. Radiol., 8, 820, 1998.
31. Hedlund, L. W. et al., Mixing oxygen with hyperpolarized (3)He for small-animal lung studies, NMR Biomed., 13, 202, 2000.
32. Ramirez, M. P. et al., Physiological response of rats to delivery of helium and xenon: implications for hyperpolarized noble gas imaging, NMR Biomed., 13, 253, 2000.
33. Chen, B. T., Yordanov, A. T., and Johnson, G. A., Ventilation-synchronous magnetic resonance microscopy of pulmonary structure and ventilation in mice, Magn. Reson. Med., 53, 69, 2005.
34. 3He, Magn. Reson. Med., 41, 787, 1999.
35. Viallon, M. et al., Dynamic imaging of hyperpolarized (3)He distribution in rat lungs using interleaved-spiral scans, NMR Biomed., 13, 207, 2000.
36. Chen, B. T., Brau, A. C. S., and Johnson, G. A., Measurement of regional lung function in rats using hyperpolarized 3Helium dynamic MRI, Magn. Reson. Med., 49, 78, 2003.
37. Hatabu, H. et al., Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery Turbo FLASH, Magn. Reson. Med., 36, 503, 1996.
38. Mai, V. M. et al., Ventilation-perfusion ratio of signal intensity in human lung using oxygen-enhanced and arterial spin labeling techniques, Magn. Reson Med., 48, 341, 2002.
39. Lipson, D. A. et al., Pulmonary ventilation and perfusion scanning using hyperpolarized helium-3 MRI and arterial spin tagging in healthy normal subjects and in pulmonary embolism and orthotopic lung transplant patients, Magn. Reson. Med., 47, 1073, 2002.
40. Berthezène, Y. et al., Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion, Radiology, 183, 667, 1992.
41. 3 He ventilation NMR study in rat lungs, Magn. Reson. Med., 41, 645, 1999.
42. Viallon, M. et al., Laser-polarized 3He as a probe for dynamic regional measurements of lung perfusion and ventilation using magnetic resonance imaging, Magn. Reson. Med., 44, 1, 2000.
43. Stupar, V. et al., Helium3 polarization using spin exchange technique: application to simultaneous pulmonary ventilation/perfusion imaging in small animals, Invest. Radiol., 38, 334, 2003.
44. Callot, V. et al., Vascular and perfusion imaging using encapsulated laser-polarized helium, MAGMA, 12, 16, 2001.
45. Callot, V. et al., Hyperpolarized helium3 encapsulated in microbubbles: a new class of blood pool MRI contrast agent, Acad. Radiol., 9(Suppl. 2), S501, 2002.
46. Dawkins, P. A. and Stockley, R. A., Animal models of chronic obstructive pulmonary disease, Thorax, 56, 972, 2001.
47. Canning, B. J., Modeling asthma and COPD in animals: a pointless exercise?, Curr. Op. Pharmacol., 3, 244, 2003.
48. Isenberg-Feig, H., Justice, J. P., and Keane-Myers, A., Animal models of allergic asthma, Curr. Allergy Asthma Rep., 3, 70, 2003.
49. Renzi, P. M., Olivenstein, R., and Martin, J. G., Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat, Am. Rev. Resp. Dis., 147, 967, 1993.
50. + T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats, Immunology, 91, 176, 1997.
51. Hannon, J. P. et al., Mechanism of airway hyperresponsiveness to adenoside induced by allergen challenge in actively sensitized Brown Norway rats, Br. J. Pharmacol., 132, 1509, 2001.
52. Watson, R. W., Redmond, H. P., and Bouchier-Hayes, D., Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses, J. Leukoc. Biol., 56, 95, 1994.
53. Yang, R. B. et al., Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling, Nature, 395, 284, 1998.
54. Albelda, S. M., Smith, C. W., and Ward, P. A., Adhesion molecules and inflammatory injury, FASEB J., 8, 504, 1994.
55. Tesfaigzi, Y. et al., Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats, Am. J. Physiol. Lung Cell Mol. Physiol., 279, L1210, 2000.
56. Tigani, B. et al., Pulmonary inflammation monitored non-invasively by MRI in freely breathing rats, Biochem. Biophys. Res. Commun., 292, 216, 2002.
57. Harkema, J. R. and Hotchkiss, J. A., In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways. Quantitative histochemistry, Am. J. Pathol., 141, 307, 1992.
58. Busch, R. H. et al., Experimental pulmonary emphysema induced in the rat by intratracheally administered elastase: morphogenesis, Environ. Res., 33, 497, 1984.
59. Riedel, M., Venous thromboembolic disease; acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosis, Heart, 1, 229, 2001.
60. Ayach, B. et al., Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism, Clin. Sci. (Lond.), 103(Suppl. 48), 371S, 2002.
61. Tigani, B. et al., Resolution of the oedema associated with allergic pulmonary inflammation in rats, Br. J. Pharmacol., 140, 239, 2003.
62. Jansson, A. H., Eriksson, C., and Wang, X., Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats, Lung, 182, 163, 2004.
63. Beckmann, N. et al., Non-invasive detection of endotoxin induced mucus hypersecretion in rat lung by magnetic resonance imaging, Am. J. Physiol. Lung Cell. Mol. Physiol., 283, L22, 2002.
64. Tigani, B. et al., Near-infrared fluorescence imaging and histology confirm anomalous edematous signal distribution detected in the rat lung by MRI after allergen challenge, J. Magn. Reson. Imaging, 20, 967, 2004.
65. Yeh, H. C., Schum, G. M., and Duggan, M. T., Anatomic models of the tracheobronchial and pulmonary regions of the rat, Anat. Rec., 195, 483, 1979.
66. Burri, P. A., Dhaly, J., and Weibel, E. R., The post-natal growth of the rat lung: I Morphometry, Anat. Rec., 178, 711, 1973.
67. Saam, B. T. et al., MR imaging of diffusion of (3)He gas in healthy and diseased lungs, Magn. Reson. Med., 44, 174, 2000.
68. Salerno, M. et al., Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes-initial experience, Radiology, 222, 252, 2002.
69. Salerno, M. et al., Rapid hyperpolarized 3He diffusion MRI of healthy and emphysematous human lungs using an optimized interleaved-spiral pulse sequence, J. Magn. Reson. Imaging, 17, 581, 2003.
70. 3He diffusion, Proc. Natl. Acad. Sci. USA, 97, 11478, 2000.
71. Peces-Barba, G., et al., Helium-3, M R I diffusion coefficient: correlation to morphometry in a model of mild emphysema, Eur. Respir. J., 22, 14, 2003.
72. Dugas, J. P. et al., Hyperpolarized (3)He MRI of mouse lung, Magn. Reson. Med., 52, 1310, 2004.
73. Chen, B. T. and Johnson, G. A., Dynamic lung morphology of methacholine-induced heterogeneous bronchoconstriction, Magn. Reson. Med., 52, 1080, 2004.
74. Dupuich, D. et al., Dynamic 3He imaging for quantification of regional lung ventilation parameters, Magn. Reson. Med., 50, 777, 2003.
75. Schumichen, C., V/Q-scanning/SPECT for the diagnosis of pulmonary embolism, Respiration, 70, 329, 2003.
76. Worsley, D. F. and Alavi, A., Radionuclide imaging of acute pulmonary embolism, Semin. Nucl. Med., 33, 259, 2003.
77. Khan, A., Cann, A. D., and Shah, R. D., Imaging of acute pulmonary emboli, Thorac. Surg. Clin., 14, 113, 2004.
78. Callot, V. et al., MR perfusion imaging using encapsulated polarized He3, Magn. Reson. Med., 46, 535, 2001.
79. Ebina, M. et al., Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: A 3-D morphometric study, Am. Rev. Respir. Dis., 148, 720, 1993.
80. Martin, J. G., Duguet, A., and Eidelman, D. H., The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease, Eur. Respir. J., 16, 349, 2000.
81. Halayko, A. J. and Amrani, Y., Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma, Respir. Physiol. Neurobiol., 137, 209, 2003.
82. Pauwels, R. A. et al., The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats, Am. Rev. Respir. Dis., 141, 540, 1990.
83. Kips, J. C. et al., The effect of a nitric oxide synthase inhibitor on the modulation of airway responsiveness in rats, Am. J. Respir. Crit. Care Med., 151, 1165, 1995.
84. Kobzik, L. et al., Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization, Am. J. Respir. Cell. Mol. Biol., 9, 371, 1993.
85. Ca channel in airway smooth muscle by nitric oxide: involvement of a nitrothiosylation mechanism?, Am. J. Respir. Cell. Mol. Biol., 19, 485, 1998.
86. Barnes, P. J., New drugs for asthma, Nat. Rev. Drug Discov., 3, 831, 2004.
87. Tigani, B. et al., Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging, Eur. J. Pharmacol., 482, 319, 2003.
88. Trifilieff, A. et al., Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2, 5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities, J. Pharmacol. Exp. Ther., 301, 241, 2002.
89. Acuna, A. A. et al., Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma, Eur. Respir. J., 19, 872, 2002.
90. Matthay, M. A., Folkesson, H. G., and Clerici, C., Lung epithelial fluid transport and the resolution of pulmonary edema, Physiol. Rev., 82, 569, 2002.
91. Chen, X.-J., Eaton, D. C., and Jain, L., b-Adrenergic regulation of amiloride-sensitive lung sodium channels, Am. J. Physiol. Lung Cell. Mol. Physiol., 282, L609, 2002.
92. Charron, P. D., Fawley, J. P., and Maron, M. B., Effect of epinephrine on alveolar liquid clearance in the rat, J. Appl. Physiol., 87, 611, 1999.
93. Goodman, B. E., Anderson, J. L., and Clemens, J. W., Evidence for regulation of sodium transport from airspace to vascular space by cAMP, Am. J. Physiol. Lung Cell. Mol. Physiol., 257, L86, 1989.
94. Beitz, E. and Schultz, J. E., The mammalian aquaporin water channel family: a promising new drug target, Curr. Med. Chem., 6, 457, 1999.
95. Towne, J. E. et al., Tumor necrosis factor-a inhibits aquaporin 5 expression in mouse lung epithelial cells, J. Biol. Chem., 276, 18657, 2001.
96. Garbow, J. R., Zhang, Z., and You, M., Detection of primary lung tumors in rodents by magnetic resonance imaging, Cancer Res., 64, 2740, 2004.
97. Heverhagen, J. T. et al., Volumetric analysis of mice lungs in a clinical magnetic resonance imaging scanner, MAGMA, 17, 80, 2004.
98. Huang, M. Q. et al., MRI detection of tumor in mouse lung using partial liquid ventilation with a perfluorocarbon-in-water emulsion, Magn. Reson. Imaging, 22, 645, 2004.
99. Schuster, D. P. et al., Recent advances in imaging the lungs of intact small animals, Am. J. Respir. Cell. Mol. Biol., 30, 129, 2004.
100. Cavanaugh, D. et al., In vivo respiratory-gated micro-CT imaging in small-animal oncology models, Mol. Imaging, 3, 55, 2004.
101. Hu, J. et al., Dynamic small animal lung imaging via a postacquisition respiratory gating technique using micro-cone beam computed tomography, Acad. Radiol., 11, 961, 2004.
102. Langheinrich, A. C. et al., Acute rat lung injury: feasibility of assessment with micro-CT, Radiology, 233, 165, 2004.